Extra Damages Bid In $22M Stent Suit Denied By Fed. Circ.

Law360, New York (October 15, 2012, 4:33 PM EDT) -- The Federal Circuit on Monday denied a bid by Spectralytics Inc. to add more than $500,000 in enhanced damages to the $22 million verdict it won in a patent infringement suit against Cordis Corp. and stent manufacturer Norman Noble Inc.

Spectralytics had argued to the appeals court that the $500,000 enhanced damages award by a trial judge was insufficient punishment for the willful infringement of a stent-cutting machine patent.

“That amount of money does not punish Cordis and will not stop them from doing anything at...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.